The Valley Desk

NCT05445778 · Interventional trial

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Overall registry status Active not recruiting

Phase 3

Conditions Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov